Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.09 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Income from Discontinued Operations (2011 - 2015)

Mosaic ImmunoEngineering (CPMV) posted Income from Discontinued Operations of -$6107.0 for Q2 2015, down 730.24% on a QoQ basis from $969.0 in Q1 2015, and down 112.6% year-over-year from $48477.0 in Q2 2014.

Analysis

Mosaic ImmunoEngineering (CPMV) Income from Discontinued Operations (2011 - 2015) Analysis & Trends

Mosaic ImmunoEngineering has reported Income from Discontinued Operations for 5 years, with the latest figure at -$6107.0 in Q2 2015.

  • On a quarterly basis, Income from Discontinued Operations fell 112.6% year-over-year to -$6107.0 in Q2 2015; TTM through Feb 2016 was -$6107.0, a 111.59% decrease from a year earlier, with the FY2015 full-year figure at -$1873.0, down 102.1% from the prior year.
  • Income from Discontinued Operations was -$6107.0 for Q2 2015 at Mosaic ImmunoEngineering, down from $969.0 in the prior quarter.
  • The five-year high for Income from Discontinued Operations was $2.5 million in Q2 2011, with the low at -$5.1 million in Q1 2011.
  • Average Income from Discontinued Operations over 5 years is -$227388.9, with a median of $465.0 recorded in 2014.
  • The sharpest annual moves came in 2013 and 2015: Income from Discontinued Operations jumped 4820.23% in 2013, then plunged 112.6% in 2015.
  • Over 5 years, Income from Discontinued Operations stood at -$329919.0 in 2011, then surged by 100.33% to $1078.0 in 2012, then slumped by 79.13% to $225.0 in 2013, then soared by 106.67% to $465.0 in 2014, then sank by 1413.33% to -$6107.0 in 2015.
  • The last three Income from Discontinued Operations figures came in at -$6107.0 (Q2 2015), $969.0 (Q1 2015), and $465.0 (Q4 2014), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Mosaic ImmunoEngineering 434,528.21 434,528.21 - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2015 -6,107.00
Feb 28, 2015 969.00
Nov 30, 2014 465.00
Aug 31, 2014 2,800.00
May 31, 2014 48,477.00
Nov 30, 2013 225.00
Aug 31, 2013 40,358.00
May 31, 2013 10,680.00
Feb 28, 2013 1,248.00
Nov 30, 2012 1,078.00
Aug 31, 2012 -855.00
May 31, 2012 -134,451.00
Feb 29, 2012 -566,722.00
Nov 30, 2011 -329,919.00
Aug 31, 2011 -332,627.00
May 31, 2011 2.47 Mn
Feb 28, 2011 -5.07 Mn